Back to Candriam S.C.A. Candriam S.C.A.

MLYSMLYS
7 quarters

Position history for Candriam S.C.A.Candriam S.C.A.'s holdings in MINERALYS THERAPEUTICS INC

Candriam S.C.A. holds 857,037 shares of MLYS (MINERALYS THERAPEUTICS INC), worth $23.1M as of 2026-Q2. The position was increased (+6.9% shares). MLYS represents 0.1% of Candriam S.C.A.'s portfolio.

Current Value

$23.1M

Current Shares

857,037

Total Value Change

+$19.3M

Total Shares Change

+551,765

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
857,037
+6.9%
$23.1M0.1%$26.98
37
2026-Q1
Increased
801,904
+18.2%
$21.7M0.1%$27.09
40
2025-Q4
Increased
678,387
+19.5%
$24.6M0.1%$36.29
40
2025-Q3
Decreased
567,781
-31.1%
$21.5M0.1%$37.92
0
2025-Q2
Decreased
824,187
-6.6%
$11.2M0.1%$13.53
0
2025-Q1
Increased
882,833
+189.2%
$14M0.1%$15.88
45
2024-Q4
New
305,272
-
$3.8M0.0%$12.31
37

Other major holders of MLYS: RA CAPITAL MANAGEMENT, L.P., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used